Orphan Drug Designation & FDA INTERACT Meeting | 17-Apr-2024 | 07:00 | RNS |
Grant of Options – PDMR/Direc... | 28-Mar-2024 | 07:00 | RNS |
Holding(s) in Company | 04-Jan-2024 | 12:30 | RNS |
Holding(s) in Company | 04-Jan-2024 | 12:30 | RNS |
BiVictriX Hosts Inaugural Roundtable Discussion | 04-Jan-2024 | 07:00 | RNS |
Board Change | 05-Dec-2023 | 11:08 | RNS |
Pipeline update on BVX002 | 30-Nov-2023 | 07:00 | RNS |
Holding(s) in Company | 22-Nov-2023 | 17:14 | RNS |
Patent Granted in Japan | 15-Nov-2023 | 07:00 | RNS |
Extended Survival Rates Reported with BVX001 | 12-Oct-2023 | 07:00 | RNS |
Appointment of Adrian Howd as CFO and CBO | 03-Oct-2023 | 07:00 | RNS |
Interim Results | 19-Sep-2023 | 07:00 | RNS |
Total Voting Rights | 31-Aug-2023 | 07:00 | RNS |
US Patent Granted | 23-Aug-2023 | 07:00 | RNS |
Holding(s) in Company | 17-Aug-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 11.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 15.90 |
52 Week Low | 10.50 |
Volume | 0 |
Shares Issued | 82.53m |
Market Cap | £9.49m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research